To include your compound in the COVID-19 Resource Center, submit it here.

Cancer; ophthalmic disease

INDICATION: Pancreatic cancer; age-related macular degeneration (AMD)

Cell culture and mouse studies suggest a SEMA3A-based fusion protein could help treat metastatic pancreatic cancer and AMD. The fusion protein

Read the full 275 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE